PortfoliosLab logo

Candel Therapeutics, Inc. (CADL)

Equity · Currency in USD · Last updated Aug 6, 2022

Company Info

ISINUS1374041093
CUSIP137404109
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$3.50
Year Range$3.05 - $11.90
EMA (50)$3.50
EMA (200)$5.52
Average Volume$8.48K
Market Capitalization$100.43M

CADLShare Price Chart


Chart placeholderClick Calculate to get results

CADLPerformance

The chart shows the growth of $10,000 invested in Candel Therapeutics, Inc. in Jul 2021 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $5,000 for a total return of roughly -50.00%. All prices are adjusted for splits and dividends.


-20.00%-10.00%0.00%10.00%20.00%30.00%40.00%MarchAprilMayJuneJulyAugust
-13.79%
-8.32%
CADL (Candel Therapeutics, Inc.)
Benchmark (^GSPC)

CADLReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M10.41%8.19%
6M-13.79%-7.42%
YTD-55.24%-13.03%
1Y-53.33%-5.85%
5Y-49.05%-5.67%
10Y-49.05%-5.67%

CADLMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-45.14%-3.96%23.54%-29.67%5.31%-14.06%-4.32%12.90%
20218.43%5.93%34.83%3.60%-7.75%-24.52%

CADLSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Candel Therapeutics, Inc. Sharpe ratio is -0.53. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-0.60-0.55-0.50-0.45-0.40-0.35-0.30-0.25Thu 28Fri 29Sat 30Jul 31AugustTue 02Wed 03Thu 04Fri 05
-0.53
-0.31
CADL (Candel Therapeutics, Inc.)
Benchmark (^GSPC)

CADLDividend History


Candel Therapeutics, Inc. doesn't pay dividends

CADLDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2022FebruaryMarchAprilMayJuneJulyAugust
-70.59%
-13.58%
CADL (Candel Therapeutics, Inc.)
Benchmark (^GSPC)

CADLWorst Drawdowns

The table below shows the maximum drawdowns of the Candel Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Candel Therapeutics, Inc. is 74.37%, recorded on Aug 1, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-74.37%Oct 27, 2021191Aug 1, 2022
-36.31%Sep 9, 20218Sep 20, 202126Oct 26, 202134
-31.95%Aug 12, 20216Aug 19, 202112Sep 7, 202118
-1.57%Jul 28, 20211Jul 28, 20211Jul 29, 20212
-1.19%Aug 2, 20211Aug 2, 20213Aug 5, 20214
-0.79%Aug 6, 20211Aug 6, 20212Aug 10, 20213

CADLVolatility Chart

Current Candel Therapeutics, Inc. volatility is 71.05%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%50.00%100.00%150.00%MarchAprilMayJuneJulyAugust
71.05%
19.67%
CADL (Candel Therapeutics, Inc.)
Benchmark (^GSPC)